A discussion of the Office of Management and Budget’s updated benefit-cost guidelines

Monday, May 22, 2023, 2:00 - 3:30 p.m. EDT
The Brookings Institution, Falk Auditorium, 1775 Massachusetts Ave NW, Washington, D.C. 20036 

On Monday, May 22, the Brookings Institution Center on Regulation and Markets and the Niskanen Center will jointly host a conversation with Richard Revesz, administrator of the U.S. Office of Information and Regulatory Affairs (OIRA), Ted Gayer, president of the Niskanen Center, Zachary Liscow, chief economist of the U.S. Office of Management and Budget (OMB), and Connor Raso, senior associate general counsel at the Public Company Accounting Oversight Board.

Sanjay Patnaik, director of the Center on Regulation and Markets, will provide welcoming remarks and Phil Wallach, senior fellow at the American Enterprise Institute, will moderate the discussion on proposed updates to OMB Circulars A-4 and A-94, which guide government benefit-cost analysis. These updates aim to reflect new developments in scientific and economic understanding, given that the current circulars are several decades old, but some may have concerns about the impact of particular proposed changes. In any case, much of the impact will depend on public comment and subsequent implementation by OMB and agencies. The program will cover the key issues to be resolved through these processes. This event is a part of the series "Reimagining Modern-day Markets and Regulations” under the Center on Regulation and Markets.

The livestreamed program will run until 3:00 p.m. and our in-person audience is invited to stay until 3:30 p.m. for informal networking. Viewers can follow along with the conversation on Twitter using the hashtag #OMB and submit questions using that hashtag or via email to events@brookings.edu.

Guests at Brookings are required to attest to their state of health before attending an event in person. Visitors may not enter the building if they are feeling ill for any reason, have any symptoms commonly associated with COVID-19, or have tested positive for COVID-19 at any time in the preceding 14 days.